[On the encephalotrophic action of hydergine. Clinical study].
D000368:Aged; D001037:Aphasia / Q000188:drug therapy; D001921:Brain / Q000187:drug effects* / Q000378:metabolism; D002543:Cerebral Hemorrhage / Q000188:drug therapy; D002561:Cerebrovascular Disorders / Q000150:complications / Q000188:drug therapy*; D004088:Dihydroergotoxine / Q000494:pharmacology / Q000627:therapeutic use*; D004877:Ergoloid Mesylates / Q000627:therapeutic use*; D005260:Female; D006429:Hemiplegia / Q000188:drug therapy; D006801:Humans; D002537:Intracranial Arteriosclerosis / Q000188:drug therapy*; D002542:Intracranial Embolism and Thrombosis / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D014717:Vertigo / Q000188:drug therapy
D004088:Dihydroergotoxine; D004877:Ergoloid Mesylates
Sull'azione encefalo-trofica dell'hydergina. Contributo clinico